Community Healthcare Trust reported third-quarter occupancy of 90.1%, up from 89.8%, and FFO of $15 million, up 10.4% year over year. It signed agreements for four properties totaling $99 million, with expected returns of 9.1% to 9.75%.
CHCT · Community Healthcare Trust Inc
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
Up next
Latest documents
Community Healthcare Trust Incorporated reported nine-month net income of $7,980 compared with $(9,326), and FFO of $41,577 compared with $32,551; figures are in thousands. Four properties under definitive purchase agreements carry an aggregate expected purchase price of approximately $99.0 million.
Community Healthcare Trust Incorporated reported $3.1 million in third-quarter net income, or $0.09 per diluted common share, and $0.54 of FFO and $0.58 of AFFO per diluted share. The Board declared a $0.33 quarterly dividend, unchanged from the prior quarter.
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
AI Brief
Q2 FY26 earnings call · Aug 5, 2026TL;DR. CHCT cut its quarterly dividend 31% to $0.33 per share, which it said will retain $25 million to $30 million over two years for acquisitions, reinvestment and occupancy improvements. The company targets 92% leased occupancy, has $99 million of acquisitions under definitive agreement, and has more than $70 million of assets marketed for sale, but transaction timing and closing remain uncertain.
- + Retaining $25 million to $30 million of capital over two years will fund acquisitions, portfolio reinvestments and occupancy improvements.
- + The company has a $99 million acquisition pipeline under definitive agreement with expected returns of 9.1% to 9.75%.
- + The company targets 92% leased occupancy, with up to $6 million of NOI upside from occupancy gains and rent growth.
- + The company expects capital recycling proceeds to fund its high-yield acquisition pipeline while keeping leverage modest.
- + Second-quarter revenue increased year over year to $31.2 million, while AFFO per share increased to $0.56 from $0.50.
- − The quarterly dividend was reduced 31% to $0.33 per share, lowering the AFFO payout ratio to approximately 60%.
- − Leased occupancy declined to 89.8% from 90.7% a year earlier.
- − The proposed sale of the geriatric behavioral hospital operator's business remains subject to documentation, due diligence and closing conditions, and the company cannot assure the timing or ultimate closing.
- − The $99 million acquisition pipeline is not assured of closing on the anticipated timetable.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| % Leased | 89.8% | 2Q 2026 | — |
| Adjusted EBITDAre non-GAAP | $23.25M | 2Q 2026 | — |
GAAP → non-GAAP reconciliationEBITDAre 20.47M (the result of another reconciliation in this filing)
+2.78M Non-cash stock-based compensation expense
+0K Accelerated amortization of stock-based compensation
+0K Credit loss reserve
= Adjusted EBITDAre 23.25M
|
|||
| Adjusted EBITDAre Annualized non-GAAP | $93M | 2Q 2026 | — |
| Adjusted funds from operations (AFFO) per Common Share-Diluted non-GAAP | $0.56 | Three Months Ended June 30, 2026 | — |
| AFFO non-GAAP | $15.41M | 2Q 2026 | — |
GAAP → non-GAAP reconciliationFFO 13.22M (non-GAAP)
-591K Straight-line rent
+2.78M Stock-based compensation
+0K Accelerated amortization of stock-based compensation
+0K Severance and transition related expenses
= AFFO 15.41M
|
|||
| AFFO Per Common Share non-GAAP | $0.56 | 2Q 2026 | — |
| Annualized NOI non-GAAP | $101.44M | 2Q 2026 | — |
| Common shares outstanding | 28,654,743 | 2Q 2026 | — |
| Debt to Total Capitalization | 43.9% | 2Q 2026 | — |
| EBITDAre non-GAAP | $20.47M | 2Q 2026 | — |
GAAP → non-GAAP reconciliationGAAP Net income (loss) 2.36M
+7.43M Interest expense
+10.74M Depreciation and amortization
-12K Deferred Income tax (benefit) expense
-46K (Gain) loss, net of impairment, on the sale of real estate assets
= EBITDAre 20.47M
|
|||
| FAD non-GAAP | $12.99M | 2Q 2026 | — |
GAAP → non-GAAP reconciliationAFFO, Adjusted for other non-cash items 15.64M (non-GAAP)
-202K Leasing commissions
-1.11M Tenant improvements
-1.34M Recurring capex
= FAD 12.99M
|
|||
| FFO non-GAAP | $13.22M | 2Q 2026 | — |
GAAP → non-GAAP reconciliationGAAP Net Income (Loss) 2.36M
+10.9M Real estate depreciation and amortization
+0K Credit loss reserve
-46K (Gain) loss, net of impairment, on the sale of real estate assets
= FFO 13.22M
|
|||
| FFO Per Common Share non-GAAP | $0.48 | 2Q 2026 | — |
| Fixed charge coverage ratio | 3 | 2Q 2026 | — |
| Funds from operations (FFO) per Common Share-Diluted non-GAAP | $0.48 | Three Months Ended June 30, 2026 | — |
| Leased occupancy Total Portfolio | 89.8% | 2Q 2026 | — |
| Leased Square Feet at end of period | 4.06M | 2Q 2026 | — |
| Minimum debt service coverage ratio | 3.2 | 2Q 2026 | — |
| NOI non-GAAP | $25.36M | 2Q 2026 | — |
GAAP → non-GAAP reconciliationGAAP Net income (loss) 2.36M
+4.89M General and administrative
+0K Accelerated amortization of deferred compensation
+0K Severance and transition-related compensation
+10.74M Depreciation and amortization
-46K (Gain) loss, net of impairment, on the sale of real estate assets
+0K Credit loss reserve
+7.43M Interest expense
-12K Deferred Income tax (benefit) expense
-3K Interest and other income, net
= NOI 25.36M
|
|||
| Portfolio Occupancy | 89.8% | Q2 2026 | — |
| Real estate properties (count) | 197 | As of June 30, 2026 | — |
| Renewals square feet | 155K | 2Q 2026 | — |
| Tangible net worth | $695.59M | 2Q 2026 | — |
| Total investments in real estate properties | $1.2B | As of June 30, 2026 | — |
| Total square feet owned | 4,520,097 | 2Q 2026 | — |
| Total square footage of properties | 4.5M | As of June 30, 2026 | — |
| Weighted average common shares outstanding - diluted | 27.75M | Three Months Ended June 30, 2026 filing | — |
| Weighted average common shares outstanding - FFO Diluted non-GAAP | 27.75M | 2Q 2026 | — |
| Weighted Average remaining lease term (years) | 7.2 | 2Q 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
REIT - Healthcare Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CHCT
this stock
Community Healthcare Trust Inc
|
$416.72M | -11.7% | +4.7% | 19.6 | 3.0% |
|
WELL
Welltower Inc.
|
$181.39B | +33.2% | +35.6% | 107.5 | 2.4% |
|
VTR
Ventas, Inc.
|
$46.64B | +14.0% | +18.5% | 166.4 | 2.8% |
|
OHI
Omega Healthcare Investors Inc
|
$14.33B | +6.2% | +13.2% | 18.9 | 4.8% |
|
AHR
American Healthcare REIT, Inc.
|
$13.59B | +24.4% | +9.1% | 117.1 | 14.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- Filed
- Nov 3, 2026
- This year
- 13
Community Healthcare Trust Incorporated reported nine-month net income of $7,980 compared with $(9,326), and FFO of $41,577 compared with $32,551; figures are in thousands. Four properties under definitive purchase agreements carry an aggregate expected purchase price of approximately $99.0 million.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CHCT | -3.4% | +14.7% | -15.8% | +11.0% | -11.7% |
| SPY | -3.9% | -5.6% | -3.5% | -3.4% | +7.1% |
| vs SPY | +0.5% | +20.3% | -12.3% | +14.4% | -18.8% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.